Hydroxytyrosol and Parkinson’s disease: protective actions against alpha-synuclein toxicity

Hydroxytyrosol and Parkinson’s disease: protective actions against alpha-synuclein toxicity

Bibliographic Details
Main Authors:	Ruth Hornedo-Ortega, Ana M Espinosa-Oliva
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-01-01
Series:	Neural Regeneration Research
Online Access:	http://www.nrronline.org/article.asp?issn=1673-5374;year=2024;volume=19;issue=7;spage=1427;epage=1428;aulast=Hornedo-Ortega

Similar Items

Evidences of hydroxytyrosol as an anti-inflammatory agent in Parkinson’s disease: insights into the mechanisms of action
by: Ruth Hornedo-Ortega, et al.
Published: (2021-01-01)

Hydroxytyrosol Decreases LPS- and α-Synuclein-Induced Microglial Activation In Vitro
by: Marta Gallardo-Fernández, et al.
Published: (2019-12-01)

Phycocyanin protects against Alpha-Synuclein toxicity in yeast
by: Diana Macedo, et al.
Published: (2017-11-01)

GALECTIN-3 SHAPES TOXIC ALPHA-SYNUCLEIN AGGREGATES IN PARKINSON´S DISEASE
by: Juan Garcia-Revilla, et al.
Published: (2023-10-01)

Alpha-Synuclein spreading in Parkinson disease
by: Ariadna eRecasens, et al.
Published: (2014-12-01)

Alpha-Synuclein Aggregation in Parkinson's Disease
by: E. Srinivasan, et al.
Published: (2021-10-01)

Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson’s disease
by: Waijiao Cai, et al.
Published: (2022-02-01)

Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity
by: Qiao Liyan, et al.
Published: (2008-11-01)

Anti-VEGF Effect of Bioactive Indolic Compounds and Hydroxytyrosol Metabolites
by: Marta Gallardo-Fernández, et al.
Published: (2022-02-01)

Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein
by: Yanina Dening, et al.
Published: (2022-12-01)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
by: Tian-Sin Fan, et al.
Published: (2021-11-01)

Alpha-synuclein as a biomarker of Parkinson’s disease
by: S. N. Pchelina
Published: (2017-02-01)

Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
by: Mónica Gómez-Benito, et al.
Published: (2020-04-01)

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
by: Luis M. A. Oliveira, et al.
Published: (2021-07-01)

The Coordinated Action of Calcineurin and Cathepsin D Protects Against α-Synuclein Toxicity
by: Andreas Aufschnaiter, et al.
Published: (2017-06-01)

Correction: The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease.
by: Rita Machado de Oliveira, et al.
Published: (2017-04-01)

Targeting alpha-synuclein as a therapy for Parkinson’s disease
by: Fields, CR, et al.
Published: (2019)

Rationale for Therapeutic Silencing of Alpha-Synuclein in Parkinson’s Disease
by: Demetrius M. Maraganore
Published: (2011-05-01)

New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
by: Guoxin Zhang, et al.
Published: (2018-11-01)

Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson’s Disease
by: Emily Fitzgerald, et al.
Published: (2019-04-01)

Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
by: Carroll Rutherford Fields, et al.
Published: (2019-12-01)

Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
by: Puyu Li, et al.
Published: (2021-10-01)

Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
by: Shengli Xu, et al.
Published: (2015-06-01)

Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson's Disease.
by: Abid Oueslati, et al.
Published: (2015-01-01)

The role of alpha-synuclein oligomers in Parkinson's disease pathophysiology and biology
by: Roberts, R
Published: (2015)

The Role of Astrocytes and Alpha-Synuclein in Parkinson’s Disease: A Review
by: David Brash-Arias, et al.
Published: (2024-03-01)

Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
by: Kamil Saramowicz, et al.
Published: (2023-12-01)

Alpha-Synuclein and the Endolysosomal System in Parkinson’s Disease: Guilty by Association
by: Maxime Teixeira, et al.
Published: (2021-09-01)

Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
by: Sindhu Menon, et al.
Published: (2022-05-01)

Macroautophagy, alpha-synuclein and dopamine neurotransmission: implications for Parkinson’s disease
by: Hunn, BHM
Published: (2017)

Olfactory deficits in an alpha-synuclein fly model of Parkinson's disease.
by: Alex Y Chen, et al.
Published: (2014-01-01)

Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
by: Richard M. Meade, et al.
Published: (2019-07-01)

Microglia Response During Parkinson’s Disease: Alpha-Synuclein Intervention
by: Sara A. Ferreira, et al.
Published: (2018-08-01)

The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease
by: Alice J. White, et al.
Published: (2018-11-01)

Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson's Disease.
by: Giorgio Vivacqua, et al.
Published: (2016-01-01)

Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease
by: Emily M. Rocha, et al.
Published: (2018-01-01)

Parkinson's disease-related protein, alpha-synuclein, in malignant melanoma.
by: Yasuhiro Matsuo, et al.
Published: (2010-05-01)

Randomized CRISPR-Cas Transcriptional Perturbation Screening Reveals Protective Genes against Alpha-Synuclein Toxicity
by: Chen, Ying-Chou, et al.
Published: (2021)

Randomized CRISPR-Cas Transcriptional Perturbation Screening Reveals Protective Genes against Alpha-Synuclein Toxicity
Published: (2019)

Sumoylation Protects Against β-Synuclein Toxicity in Yeast
by: Blagovesta Popova, et al.
Published: (2018-03-01)